Stock Track | BEAUTYFARM MED Plummets 10.62% Intraday on Investor Concerns Over Profit Sustainability After Strong Earnings

Stock Track
03/30

BEAUTYFARM MED's stock plummeted 10.62% during intraday trading on Monday, marking a significant downward movement for the healthcare company.

The sharp decline followed the release of the company's 2025 annual results, which showed strong financial performance with revenue increasing 16.7% year-on-year to approximately RMB 3 billion and adjusted net profit surging 41% to about RMB 381 million. Despite these positive figures, investors expressed concerns about whether the company can sustain this profit growth momentum going forward.

Chief Financial Officer Zhou Min addressed these concerns by stating that BEAUTYFARM MED expects to maintain profit growth through organic expansion and strategic acquisitions. The company plans to invest in brand development and digital transformation for 2026, using efficiency gains to fund future growth initiatives.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10